These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24370840)

  • 1. A novel aqueous parenteral formulation of docetaxel using prodrugs.
    Park MH; Keum CG; Song JY; Kim D; Cho CW
    Int J Pharm; 2014 Feb; 462(1-2):1-7. PubMed ID: 24370840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of docetaxel solubility using binary and ternary solid dispersion systems.
    Lim SM; Pang ZW; Tan HY; Shaikh M; Adinarayana G; Garg S
    Drug Dev Ind Pharm; 2015; 41(11):1847-55. PubMed ID: 25721984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced antitumor efficacy and decreased toxicity by self-associated docetaxel in phospholipid-based micelles.
    Tong SW; Xiang B; Dong DW; Qi XR
    Int J Pharm; 2012 Sep; 434(1-2):413-9. PubMed ID: 22698861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two kinds of docetaxel-vitamin E prodrugs: In vitro evaluation and in vivo antitumor activity.
    Wang J; Xue P; Zhou J; Li L; Xu L; Wang Y
    Int J Pharm; 2016 May; 505(1-2):352-60. PubMed ID: 27085643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano-sized assemblies of a PEG-docetaxel conjugate as a formulation strategy for docetaxel.
    Liu J; Zahedi P; Zeng F; Allen C
    J Pharm Sci; 2008 Aug; 97(8):3274-90. PubMed ID: 18064681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docetaxel/2-Hydroxypropyl β -Cyclodextrin Inclusion Complex Increases Docetaxel Solubility and Release from a Nanochannel Drug Delivery System.
    Ferrati S; Nicolov E; Bansal S; Hosali S; Landis M; Grattoni A
    Curr Drug Targets; 2015; 16(14):1645-9. PubMed ID: 25706254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation of parenteral microemulsion containing itraconazole.
    Rhee YS; Park CW; Nam TY; Shin YS; Chi SC; Park ES
    Arch Pharm Res; 2007 Jan; 30(1):114-23. PubMed ID: 17328251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Injectable and biodegradable poly(organophosphazene) hydrogel as a delivery system of docetaxel for cancer treatment.
    Cho JK; Hong JM; Han T; Yang HK; Song SC
    J Drug Target; 2013 Jul; 21(6):564-73. PubMed ID: 23594096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, characterization, and in vivo efficacy evaluation of PGG-docetaxel conjugate for potential cancer chemotherapy.
    Yang D; Van S; Shu Y; Liu X; Ge Y; Jiang X; Jin Y; Yu L
    Int J Nanomedicine; 2012; 7():581-9. PubMed ID: 22334784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in the development of alternative pharmaceutical formulations of taxanes.
    Nuijen B; Bouma M; Schellens JH; Beijnen JH
    Invest New Drugs; 2001 May; 19(2):143-53. PubMed ID: 11392448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable and efficient delivery of docetaxel by micelle-encapsulation using a tripodal cyclotriphosphazene amphiphile.
    Jun YJ; Jadhav VB; Min JH; Cui JX; Chae SW; Choi JM; Kim IS; Choi SJ; Lee HJ; Sohn YS
    Int J Pharm; 2012 Jan; 422(1-2):374-80. PubMed ID: 22079718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of PEGylated biodegradable nanoparticles for sustained release of docetaxel in triple-negative breast cancer.
    Palma G; Conte C; Barbieri A; Bimonte S; Luciano A; Rea D; Ungaro F; Tirino P; Quaglia F; Arra C
    Int J Pharm; 2014 Oct; 473(1-2):55-63. PubMed ID: 24992317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel.
    Liu D; Liu Z; Wang L; Zhang C; Zhang N
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):262-9. PubMed ID: 21435845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and cellular uptake behavior of redox-sensitive docetaxel prodrug-loaded liposomes.
    Ren G; Jiang M; Guo W; Sun B; Lian H; Wang Y; He Z
    Pharm Dev Technol; 2018 Jan; 23(1):22-32. PubMed ID: 28121230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic modification of carboxymethylcellulose and use thereof to prepare a nanoparticle forming conjugate of docetaxel for enhanced cytotoxicity against cancer cells.
    Ernsting MJ; Tang WL; MacCallum N; Li SD
    Bioconjug Chem; 2011 Dec; 22(12):2474-86. PubMed ID: 22014112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel sulforaphane-enabled self-microemulsifying delivery systems (SFN-SMEDDS) of taxanes: Formulation development and in vitro cytotoxicity against breast cancer cells.
    Kamal MM; Nazzal S
    Int J Pharm; 2018 Jan; 536(1):187-198. PubMed ID: 29195916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a solid supersaturatable self-emulsifying drug delivery system of docetaxel with improved dissolution and bioavailability.
    Chen Y; Chen C; Zheng J; Chen Z; Shi Q; Liu H
    Biol Pharm Bull; 2011; 34(2):278-86. PubMed ID: 21415541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inclusion complexation of diazepam with different cyclodextrins in formulations for parenteral use.
    Holvoet C; Heyden YV; Plaizier-Vercammen J
    Pharmazie; 2005 Aug; 60(8):598-603. PubMed ID: 16124403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfobutylether-β-cyclodextrin/chitosan nanoparticles enhance the oral permeability and bioavailability of docetaxel.
    Wu J; Shen Q; Fang L
    Drug Dev Ind Pharm; 2013 Jul; 39(7):1010-9. PubMed ID: 22681515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pluronic F-127 Stabilised Docetaxel Nanocrystals Improve Apoptosis by Mitochondrial Depolarization in Breast Cancer Cells: Pharmacokinetics and Toxicity Assessment.
    Pawar VK; Gupta S; Singh Y; Meher JG; Sharma K; Singh P; Gupta A; Bora HK; Chaurasia M; Chourasia MK
    J Biomed Nanotechnol; 2015 Oct; 11(10):1747-63. PubMed ID: 26502638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.